New medicines to improve control and contribute to the eradication of malaria [PDF]
, 2010 Timothy N. C. Wells
openalex +1 more source
Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine
Molecular Oncology, EarlyView.The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu +18 more
wiley +1 more source
Mentoring Medical Students in Patient Safety and Quality Improvement: Exploring Faculty Confidence and Leadership. [PDF]
J Med Educ Curric DevInayat A +8 more
europepmc +1 more source
Save the Date: Digital Discovery Conference, March 27, 2008 Vol.6 (1) January - February 2008 [PDF]
, 2008 Houston Academy of Medicine-Texas Medical Center Library
core +1 more source
A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression
Molecular Oncology, EarlyView.Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak +8 more
wiley +1 more source
RETRACTED: Mancinelli et al. The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling. <i>Cells</i> 2022, <i>11</i>, 1591. [PDF]
CellsMancinelli R +17 more
europepmc +1 more source
Dinner With...Houston\u27s Most Fascinating, Vol.19 (2) October - December 2005 [PDF]
, 2005 Houston Academy of Medicine-Texas Medical Center Library
core +1 more source